A Phase I/II Pilot Study of the Safety of the Adoptive Transfer of Syngeneic Gene-Modified Cytotoxic T Lymphocytes in HIV-Infected Identical Twins. National Institutes of Health, Bethesda, Maryland-Reference-Cited by-同舟云学术

A Phase I/II Pilot Study of the Safety of the Adoptive Transfer of Syngeneic Gene-Modified Cytotoxic T Lymphocytes in HIV-Infected Identical Twins. National Institutes of Health, Bethesda, Maryland

Published:1996-02-10 Issue:3 Volume:7 Page:367-400
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Walker Robert E.,Blaese R. Michael,Davey Richard T.,Falloon Judith,Mullen Craig,Polis Michael A.,Finer Mitch,McGuire Brian,Roberts Margo,Zsebo Kris,Havrilla Nancy

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/hum.1996.7.3-367

Reference31 articles.

1. Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS

2. Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)

3. Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS

4. Epidemiology of HIV Infection and AIDS in the United States

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Problems and solutions to successful gene-transfer based therapies for HIV;Clinical and Applied Immunology Reviews;2003-01

2. Development and application of receptor-modified T lymphocytes for adoptive immunotherapy;Transfusion Medicine Reviews;2001-01

3. T-Bodies as Antiviral Agents;Current Topics in Microbiology and Immunology;2001

4. Antisense RNA sequences targeting the 5′ leader packaging signal region of human immunodeficiency virus type-1 inhibits viral replication at post-transcriptional stages of the life cycle;Gene Therapy;2000-08

5. Expression of the activation antigen CD69 predicts functionality of in vitro expanded peripheral blood mononuclear cells (PBMC) from healthy donors and HIV-infected patients;Clinical and Experimental Immunology;1998-10